Jacobs Levy Equity Management’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-617,010
Closed -$5.8M 968
2026
Q1
$5.8M Buy
+617,010
New +$5.53M 0.02% 390
2024
Q4
Sell
-546,909
Closed -$7.35M 950
2024
Q3
$7.35M Buy
+546,909
New +$8.06M 0.03% 378
2023
Q4
Sell
-370,224
Closed -$9.18M 988
2023
Q3
$9.18M Buy
370,224
+144,035
+64% +$3.62M 0.05% 272
2023
Q2
$6.35M Sell
226,189
-642,750
-74% -$16M 0.04% 345
2023
Q1
$19.4M Buy
868,939
+697,447
+407% +$18.3M 0.12% 193
2022
Q4
$4.56M Buy
171,492
+4,392
+3% +$143K 0.03% 413
2022
Q3
$4.74M Sell
167,100
-183,298
-52% -$4.71M 0.04% 404
2022
Q2
$7.3M Sell
350,398
-43,091
-11% -$807K 0.06% 343
2022
Q1
$8.53M Buy
+393,489
New +$8.54M 0.06% 327
2021
Q4
Sell
-12,935
Closed -$275K 982
2021
Q3
$275K Hold
12,935
﹤0.01% 950
2021
Q2
$214K Sell
12,935
-149,651
-92% -$2.28M ﹤0.01% 978
2021
Q1
$2.03M Sell
162,586
-109,431
-40% -$1.16M 0.02% 594
2020
Q4
$2.41M Sell
272,017
-1,557
-0.6% -$12.7K 0.02% 539
2020
Q3
$1.77M Sell
273,574
-54,741
-17% -$347K 0.02% 539
2020
Q2
$2.02M Buy
328,315
+26,148
+9% +$160K 0.02% 531
2020
Q1
$2.04M Sell
302,167
-3,496
-1% -$33.1K 0.03% 470
2019
Q4
$3.55M Buy
305,663
+42,348
+16% +$478K 0.03% 434
2019
Q3
$2.71M Buy
263,315
+3,000
+1% +$29.5K 0.03% 451
2019
Q2
$2.44M Buy
260,315
+215,541
+481% +$1.66M 0.03% 486
2019
Q1
$315K Buy
+44,774
New +$384K ﹤0.01% 836
2014
Q3
Sell
-13,665
Closed -$89K 831
2014
Q2
$89K Sell
13,665
-25,535
-65% -$169K ﹤0.01% 807
2014
Q1
$316K Buy
+39,200
New +$386K 0.01% 748

Other funds holding CCRN

Jacobs Levy Equity Management's CCRN Position: Q2 2026 in Review

Jacobs Levy Equity Management sold out of Cross Country Healthcare (CCRN) in Q2 2026, closing a stake of 617,010 shares — an estimated $5.8M sold.

Jacobs Levy Equity Management first reported a position in CCRN in Q1 2014 and held it in 22 quarters. The position peaked at $19.4M in Q1 2023. 151 funds tracked by Wall St. Rank hold CCRN as of Q2 2026.

  • Jacobs Levy Equity Management reported no remaining Cross Country Healthcare position as of Q2 2026 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 617,010 Cross Country Healthcare shares in Q2 2026, an estimated $5.8M.
  • Jacobs Levy Equity Management first reported a position in Cross Country Healthcare in Q1 2014 and held it in 22 quarters.
  • Jacobs Levy Equity Management's Cross Country Healthcare position peaked at $19.4M in Q1 2023.
  • 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.